Azenta US Inc.

Azenta US Inc., operating as Brooks Life Sciences Inc., is a for-profit subsidiary of Azenta, Inc. providing genomic sequencing services, cryogenic sample storage systems, biorepository management, and laboratory software solutions to federal agencies as a prime contractor (90% of recent awards) and subcontractor on life sciences research programs. The company competes on a full-and-open basis with no small business set-aside designations, headquartered in Indianapolis, Indiana.

The company's federal customer concentration centers on the National Institutes of Health and the Department of Veterans Affairs. The top five funding entities by dollar value account for 92% of combined potential value: the Department of Veterans Affairs Veterans Integrated Service Network 4 anchors the portfolio with 10 awards carrying $109.6 million combined potential value, largely driven by a single $2.0 million nitrostore maintenance and service contract running through December 2026; the National Cancer Institute carries five awards worth $87.2 million, headlined by a $35.0 million Childhood Cancer Data Initiative award for multi-omics molecular characterization research (whole exome, whole genome, transcriptome, proteomics, metabolomics, single-cell analysis) running through December 2029 and invoicing $3.4 million in FY2025; the National Heart, Lung, and Blood Institute holds four awards for $5.6 million, including a $5.5 million purchase order for an automated -80 degrees Celsius ultra-low temperature freezer system; and the National Institute of Environmental Health Sciences and National Institute of Allergy and Infectious Diseases round out the top five with 12 and 24 awards respectively, totaling $4.2 million and $514 thousand in potential value. The split between award volume and dollar value reflects Azenta's mix of small genomic service orders and high-dollar equipment and multi-year service contracts: 42% of awards by count go to five top customers, while those same customers represent 92% of potential value.

The company holds four active indefinite delivery vehicles anchoring its federal pipeline. The Department of Veterans Affairs IDIQ VA24013D0054 has generated eight task orders worth $32.6 million combined potential value for DNA sequencing services, with delivery orders ranging from $8,000 to $48,000 drawn against a negotiated ceiling; the USDA Agricultural Research Service Pacific West Area granted a single-award IDIQ ceiling of $337,920 for DNA sequencing (whole exome, whole genome, transcriptome, single-cell analysis) with two task orders issued to date; the National Institute of Environmental Health Sciences awarded a $10 million single-award Blanket Purchase Agreement (ultimate completion August 31, 2026) for biological materials, laboratory supplies, and laboratory testing services, with three task orders recorded for plasmid libraries totaling $62 thousand; and the USDA Office of Acquisitions and Grants established a $150,000 single-award IDIQ for RNA extraction and sequencing services (ultimate completion August 14, 2028). Representative prime work includes high-throughput sequencing bee sample analysis ($99.6 thousand, Southeast Area, September 2026), integrated multiomics profiling of 97 cattle samples for $241.4 thousand (USDA Agricultural Research Service, September 2026), and RNA sequencing for the TRACTS (Traumatic Brain Injury and Stress Disorders) study at VA Boston ($110 thousand, Department of Veterans Affairs, September 2025).

Activity has declined from 35 awards in 2023 to 11 in 2026 year-to-date, with 13 awards (combined potential value $9.2 million) facing ultimate completion inside the next twenty-four months and therefore exposure to recompete. SCI-reportable invoiced revenue on prime service contracts above the $150,000 reporting threshold totaled $3.4 million in FY2025, with roughly 4.6 FTEs delivering services to the federal government in that fiscal year. The SCI dataset covers federal services contracts only and excludes the company's substantial goods revenue from equipment sales and product licensing. Across SCI-reportable prime contracts, subcontractors performed zero percent of total hours; Azenta reported one named subcontractor across its SCI prime portfolio, indicating predominantly in-house delivery on service contract work captured in SCI.

Azenta operates as a subcontractor to Arete Associates on multiple task orders for DNA extraction and 16S-EZ library preparation (four sub-awards through December 2023) and to ModernaTx, Inc. on a COVID-19 mRNA vaccine development program involving sample storage services (one sub-award, September 2022). The company serves as a named sub-recipient on NIH Immune Tolerance Network grants through Benaroya Research Institute at Virginia Mason, providing biorepository services, PBMC processing, and cell isolation for clinical trials (nine sub-grant awards from July 2024 through May 2026).

The company's federal work concentrates on NAICS codes 541380 (Testing Laboratories and Services), 541711 (Research and Development in the Physical, Engineering, and Life Sciences except Nanotechnology and Biotechnology), and 541714 (Research and Development in Biotechnology except Nanobiotechnology), with PSC Reference Laboratory Testing accounting for 30 awards across the portfolio. The federal award footprint spans high-throughput sequencing, RNA and DNA analysis, cryogenic equipment and maintenance, biobanking software licensing (FreezerPro, LIMFINITY platforms), and specialized assays (ATAC-seq, Olink proximity extension assays, single-cell RNA sequencing). The company also supplies plasmid libraries, oligos, and molecular biology consumables to support federal research missions.